INDICATIVE price disclosure-related price changes have been posted by the Pharmaceutical Benefits Scheme at pbs.gov.au.
Epirubicin price in varying strengths is to drop by almost 45% while idarubicin and irinotecan will fall by nearly 40% compared to Oct 2018 pricing.
A total of 62 products are named in the Apr cycle.
The above article was sent to subscribers in Pharmacy Daily's issue from 21 Jan 19
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 21 Jan 19